28 related articles for article (PubMed ID: 7782152)
1. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.
Azinovic I; DeNardo GL; Lamborn KR; Mirick G; Goldstein D; Bradt BM; DeNardo SJ
Cancer Immunol Immunother; 2006 Dec; 55(12):1451-8. PubMed ID: 16496145
[TBL] [Abstract][Full Text] [Related]
2. A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma.
Fulciniti M; Hideshima T; Vermot-Desroches C; Pozzi S; Nanjappa P; Shen Z; Patel N; Smith ES; Wang W; Prabhala R; Tai YT; Tassone P; Anderson KC; Munshi NC
Clin Cancer Res; 2009 Dec; 15(23):7144-52. PubMed ID: 19934301
[TBL] [Abstract][Full Text] [Related]
3. Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.
Legouffe E; Liautard J; Gaillard JP; Rossi JF; Wijdenes J; Bataille R; Klein B; Brochier J
Clin Exp Immunol; 1994 Nov; 98(2):323-9. PubMed ID: 7955540
[TBL] [Abstract][Full Text] [Related]
4. Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival.
Miotti S; Negri DR; Valota O; Calabrese M; Bolhuis RL; Gratama JW; Colnaghi MI; Canevari S
Int J Cancer; 1999 Feb; 84(1):62-8. PubMed ID: 9988234
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes.
Lamers CH; Gratama JW; Warnaar SO; Stoter G; Bolhuis RL
Int J Cancer; 1995 Feb; 60(4):450-7. PubMed ID: 7829257
[TBL] [Abstract][Full Text] [Related]
6. Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA).
Papoian R
J Immunoassay; 1992; 13(2):289-96. PubMed ID: 1430244
[TBL] [Abstract][Full Text] [Related]
7. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulating IL-6 activity by murine monoclonal antibodies.
Brochier J; Legouffe E; Liautard J; Gaillard JP; Mao LQ; Bataille R; Rossi JF; Klein B
Int J Immunopharmacol; 1995 Jan; 17(1):41-8. PubMed ID: 7782152
[TBL] [Abstract][Full Text] [Related]
9. [Production of human antimurine antibody after in vivo use of radioisotope labelled murine antibodies].
Toft JC; Tromholt N
Ugeskr Laeger; 1991 Sep; 153(40):2813-5. PubMed ID: 1926613
[TBL] [Abstract][Full Text] [Related]
10. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.
Trikha M; Corringham R; Klein B; Rossi JF
Clin Cancer Res; 2003 Oct; 9(13):4653-65. PubMed ID: 14581334
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
Greiner JW; Guadagni F; Hand PH; Pestka S; Noguchi P; Fisher PB; Schlom J
Cancer Treat Res; 1990; 51():413-32. PubMed ID: 1977458
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
